<div class="content-intro"><p class="p1"><strong>About Celea Therapeutics</strong></p> <p class="p2"><span data-teams="true">Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. Drawn from the Latin word for “sky,” our name reflects our mission to rise above the status quo and deliver therapies that change lives. Our lead program, deupirfenidone (LYT-100), is currently in Phase 3 clinical development with active candidate enrollment, representing a potential new standard of care for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.</span></p> <p class="p2">Rising above the status quo takes a team as strong as its science, and we hire and work by five values: <strong>accountability</strong> — owning outcomes and acting like owners; <strong>transparency</strong> — talking straight and building trust; <strong>collaboration</strong> — achieving together what no one could alone; <strong>innovation</strong> — challenging accepted ideas and taking smart risks; and <strong>passion</strong> — bringing energy and heart to the mission. </p></div><p><strong><span data-contrast="none">Position Overview</span></strong><span data-ccp-props="{"335559738":280,"335559739":120}"> </span></p> <p><span data-contrast="auto">As we prepare for our next stage of growth and clinical advancement, Celea is seeking an experienced, strategic, and hands-on Vice President of Regulatory Affairs to lead our global regulatory strategy and serve as our primary advocate with the FDA and other international health authorities as we advance deupirfenidone (LYT-100) through Phase 3 development toward registration. Reporting to the Chief Medical Officer, this role will be a member of the Celea Leadership Team and will own regulatory strategy, agency interactions, and submissions across all of our development programs while also personally leading the preparation of high-quality regulatory filings — from briefing documents and health authority meetings through the planned NDA/MAA.</span><span data-ccp-props="{"335559739":160}"> </span></p> <p><span data-contrast="auto">In the near term, the focus will be supporting Phase 3 execution and the regulatory interactions and submissions that, together with our Phase 2b results, could serve as the basis for registration in the U.S. and other geographies. Over time, this person will build and scale the regulatory function, establish robust regulatory processes and infrastructure, and help prepare Celea for approval and commercialization, and will be instrumental in guiding Celea through its next chapter.</span><span data-ccp-props="{"335559739":160}"> </span></p> <p><span data-contrast="auto">This position is based in the Greater Boston area, with a hybrid working model.</span><span data-ccp-props="{"335559739":160}"> </span></p> <p><strong><span data-contrast="none">Key Responsibilities</span></strong><span data-ccp-props="{"335559738":280,"335559739":120}"> </span></p> <ul> <li data-leveltext="•" data-font="" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":431,"335559991":259,"469769242":[8226],"469777803":"left","469777804":"•","469777815":"hybridMultilevel"}" data-aria-posinset="1" data-aria-level="1"><span data-contrast="auto">Lead Celea's Global Regulatory Affairs Function; own the formulation of overall regulatory strategy and tactical plans to achieve the Company’s regulatory goals across all programs.</span><span data-ccp-props="{"335559739":80}"> </span></li> </ul> <ul> <li data-leveltext="•" data-font="" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":431,"335559991":259,"469769242":[8226],"469777803":"left","469777804":"•","469777815":"hybridMultilevel"}" data-aria-posinset="2" data-aria-level="1"><span data-contrast="auto">Oversee all regulatory submissions and interactions from pre-IND through NDA/MAA filings, as well as all filings with health authorities on a global basis.</span><span data-ccp-props="{"335559739":80}"> </span></li> </ul> <ul> <li data-leveltext="•" data-font="" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":431,"335559991":259,"469769242":[8226],"469777803":"left","469777804":"•","469777815":"hybridMultilevel"}" data-aria-posinset="3" data-aria-level="1"><span data-contrast="auto">Develop trusted, productive relationships with FDA and international health authorities, serving as the Company’s primary liaison in agency meetings and negotiations.</span><span data-ccp-props="{"335559739":80}"> </span></li> </ul> <ul> <li data-leveltext="•" data-font="" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":431,"335559991":259,"469769242":[8226],"469777803":"left","469777804":"•","469777815":"hybridMultilevel"}" data-aria-posinset="4" data-aria-level="1"><span data-contrast="auto">Provide direct regulatory oversight of preclinical, clinical, and CMC activities; review and endorse key development documents, including target labeling, pivotal protocols and study designs, analytical plans, and risk management plans.</span><span data-ccp-props="{"335559739":80}"> </span></li> </ul> <ul> <li data-leveltext="•" data-font="" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":431,"335559991":259,"469769242":[8226],"469777803":"left","469777804":"•","469777815":"hybridMultilevel"}" data-aria-posinset="5" data-aria-level="1"><span